The Competition Commission of India has approved the sale of Kraft Heinz Co.'s Indian business, including a portfolio of several brands, to Indian pharmaceutical company Cadila Healthcare Ltd. and its consumer products division Zydus Wellness Ltd.
The competition watchdog announced the decision in a Dec. 11 tweet, without disclosing further details.
Zydus and Kraft Heinz confirmed the 45.95 billion Indian rupee deal in separate announcements in October.
Heinz India Pvt. Ltd.'s brands include children's drink Complan, energy drink Glucon D, Nycil talcum powder and Sampriti butter.
As of Dec. 11, US$1 was equivalent to 72.30 Indian rupees.